Related Experiment Video
Updated: Jan 24, 2026
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
Next-generation sequencing analysis of embryos from mosaic patients undergoing in vitro fertilization
Keli Luo1, Yueyun Lan2, Pingyuan Xie3
1Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Hunan, People's Republic of China; Reproductive and Genetic Hospital of Citic-Xiangya, Hunan, People's Republic of China; Key Laboratory of Reproductive and Stem Cell Engineering, National Health and Family Planning Commission, Changsha, People's Republic of China.
Objective:
To investigate the effects of parental mosaicism on their preimplantation embryos.
Design:
Case series.
Setting:
An institute for reproductive and stem cell engineering.
Patient(S):
Sixty-eight mosaic couples.
Intervention(S):
Assisted reproduction with preimplantation genetic testing (PGT).
Main Outcome Measure(S):
Karyotypes, embryo-related chromosomal abnormalities, and PGT results.
Result(S):
A total of 209 embryos were obtained from 68 mosaic couples, and 153 (73.21%) of 209 of the total embryos were obtained from 55 mosaic couples with abnormal sex chromosome numbers. Of these 153 embryos, 2 (1.31%) had an abnormal copy number of X chromosome, 1 had mosaicism with 46,XN,+X(mosaic, 40%), 1 (0.65%) had an extra Y chromosome, 3 (1.96%) exhibited both X chromosomal and autosomal abnormalities, and 4 (2.61%) exhibited de novo X chromosome structural abnormalities. A total of 56 (26.79%) of 209 embryos were obtained from mosaic couples (n = 13) with abnormal autosomal structures. Notably, of these 56 embryos, 5 (8.93%) had a 16q21-q24.3 copy number abnormality related to the parental karyotype, with a fragile site at 16q22; 5 (7.14%) exhibited 46,XX,dup(8p23.1-8p11.21) and 46,XY,del(8p22-8p11.21), which were related to the parental karyotype; and 10 (17.86%) were de novo chromosome abnormalities.
Conclusion(S):
Our data demonstrate that the risk of embryo-related chromosome abnormalities in mosaic patients with abnormal sex chromosomes is very low. Therefore, PGT may not need to be recommended for mosaic patients with abnormal copy numbers of sex chromosomes, especially for patients with financial difficulties. By contrast, the mosaic patients with structural abnormalities of autosomes may have a relatively high risk of abnormal embryos with an unbalanced segment of the involved chromosomes. Thus, PGT is highly recommended for mosaic patients with autosomal structure abnormalities, especially those with a fragile site at 16q22.
Related Concept Videos
01:24In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
01:34The Fluid Mosaic Model
03:00Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
02:59Animal Mitochondrial Genetics
00:49What is Genetic Engineering?
01:38Fertilization